RDGT China Jo-Jo Drugstores: EV/EBITDA Multiple

China Jo-Jo Drugstores, Inc. - graphic logo of issuer RDGT

China Jo-Jo Drugstores, Inc (RDGT) operates a network of Chinese pharmacies and digital services, countering intense pricing pressure from regional IT giants by developing local skincare. The market price action based on the EV/EBITDA multiple is currently 0.00. The company's growth relies on the expansion of O2O delivery, the opening of new clinics, and government initiatives to shift the sale of prescription drugs into the retail sector.

China Jo-Jo Drugstores, Inc. - RDGT Business Value to Operating Income Before Depreciation (period 11/23/2025 - 11/19/2026)

China Jo-Jo Drugstores - analytical breakdowns and key metrics (RDGT)

Fundamental company analysis:China Jo-Jo Drugstores, Inc (RDGT)
Original product of jiuzhou360.com

Investors view China Jo-Jo Drugstores, Inc (RDGT) as a stable asset with moderate growth potential. This metric compares the total enterprise value, including debt, with earnings before interest, taxes, depreciation, and amortization, which isolates the valuation from the impact of debt loads and tax regimes. Analyzing the EV/EBITDA multiple chart reveals how China Jo-Jo Drugstores, Inc (RDGT)'s digital pharmacy retail ecosystem converts customer loyalty into sustainable market capitalization.